Fremanezumab for Episodic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials.
Kazumasa SaigohTakao TakeshimaMasami NakaiYoshiyuki ShibasakiMiki IshidaXiaoping NingSteve BarashYuki IsogaiNobuyuki KogaPublished in: Journal of pain research (2023)
Fremanezumab appears to be an effective and well-tolerated preventive medication for Japanese patients with EM.